Researchers analyzed the charts of more than 2,000 adult patients discharged with community outpatient parenteral antimicrobial therapy from 2013 to 2014.
Of those patients, just five (0.73 percent) developed community onset C. difficile. All five of these patients had a recent exposure to a healthcare facility. Two of the five patients had hospital readmissions not related to the C. difficile infection, and four of the five were on concomitant acid suppressive therapy, according to the study.
Researchers indicate that hospital exposure and antimicrobial therapy are risk factors for developing C. difficile.
More articles on C. difficile:
Cubist reports positive preliminary results with C. diff drug
C. diff rates soar over 10 years
C. diff increases mortality risk in cirrhosis patients
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
